Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 2/2010

01-08-2010 | Reproductive Medicine

A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles

Authors: Yong Jin Kim, Seung-Yup Ku, Byung Chul Jee, Chang Suk Suh, Seok Hyun Kim, Young Min Choi, Jung Gu Kim, Shin Yong Moon

Published in: Archives of Gynecology and Obstetrics | Issue 2/2010

Login to get access

Abstract

Purpose

This study was performed to compare the outcomes of controlled ovarian stimulation (COH) and IVF between women with PCOS and those with sonographic PCO-only in GnRH antagonist cycles.

Methods

This was a retrospective study of women with PCOS (n = 42) and those with sonographic PCO-only (n = 54) undergoing IVF. Responses to COH, adverse events such as severe ovarian hyperstimulation syndrome (OHSS), embryological and pregnancy outcomes were compared between the two groups using GnRH antagonist cycles and between GnRH agonist and antagonist protocols in the two groups, respectively.

Results

There were no differences in the duration of stimulation, dose of gonadotropins used, E2 level on hCG day, numbers of retrieved oocytes, and incidence of sever OHSS between PCOS and sonographic PCO-only groups, which was also observed both in GnRH agonist and antagonist subgroups. Pregnancy rates between PCOS and sonographic PCO-only groups in GnRH agonist (21.7 vs. 34.4%, P = 0.238) and antagonist (26.3 vs 22.7%, P = 0.537) subgroups did not differ. In regard to COH regimen, GnRH agonist long protocols showed higher responses than antagonist protocols both in PCOS group [number of retrieved oocytes (13.2 ± 5.8 vs. 8.2 ± 3.2, P < 0.001)] and sonographic PCO-only group [number of retrieved oocytes (13.7 ± 5.2 vs. 9.2 ± 6.7, P = 0.008); E2 level on hCG day (3,005.1 ± 1,317.1 vs. 1,525.9 ± 738.6 pg/mL, P < 0.001)].

Conclusions

Women with PCOS and sonographic PCO-only may have similar outcome during COH cycle for IVF.
Literature
1.
go back to reference Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749CrossRefPubMed Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749CrossRefPubMed
2.
go back to reference The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos). Hum Reprod 19(1):41–47CrossRef The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos). Hum Reprod 19(1):41–47CrossRef
3.
go back to reference Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545–2549CrossRefPubMed Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545–2549CrossRefPubMed
4.
go back to reference Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9(6):505–514CrossRefPubMed Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9(6):505–514CrossRefPubMed
5.
go back to reference Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, Balen A, Dunger D (2001) Clinical features in women with polycystic ovaries: Relationships to insulin sensitivity, insulin gene vntr and birth weight. Clin Endocrinol (Oxf) 55(4):439–446CrossRef Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, Balen A, Dunger D (2001) Clinical features in women with polycystic ovaries: Relationships to insulin sensitivity, insulin gene vntr and birth weight. Clin Endocrinol (Oxf) 55(4):439–446CrossRef
6.
go back to reference Schenker JG (1993) Prevention and treatment of ovarian hyperstimulation. Hum Reprod 8(5):653–659PubMed Schenker JG (1993) Prevention and treatment of ovarian hyperstimulation. Hum Reprod 8(5):653–659PubMed
7.
go back to reference Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140(7):815–830PubMed Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140(7):815–830PubMed
8.
go back to reference Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY (2008) Follicular fluid anti-mullerian hormone and inhibin b concentrations: comparison between gonadotropin-releasing hormone (gnrh) agonist and gnrh antagonist cycles. Fertil Steril 89(4):860–867CrossRefPubMed Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY (2008) Follicular fluid anti-mullerian hormone and inhibin b concentrations: comparison between gonadotropin-releasing hormone (gnrh) agonist and gnrh antagonist cycles. Fertil Steril 89(4):860–867CrossRefPubMed
9.
go back to reference Moon SY, Choi YS, Ku SY, Kim SH, Choi YM, Kang IS, Kim CH (2007) Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (da-3801) with follitropin-alpha (Gonal-f) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology. J Obstet Gynaecol Res 33(3):305–315CrossRefPubMed Moon SY, Choi YS, Ku SY, Kim SH, Choi YM, Kang IS, Kim CH (2007) Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (da-3801) with follitropin-alpha (Gonal-f) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology. J Obstet Gynaecol Res 33(3):305–315CrossRefPubMed
10.
11.
go back to reference The Practice Committee of the American Society for Reproductive Medicine (2004) Ovarian hyperstimulation syndrome. Fertil Steril 82(Suppl 1):S81–S86 The Practice Committee of the American Society for Reproductive Medicine (2004) Ovarian hyperstimulation syndrome. Fertil Steril 82(Suppl 1):S81–S86
12.
go back to reference Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P (2007) Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril 88(5):1382–1388CrossRefPubMed Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P (2007) Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril 88(5):1382–1388CrossRefPubMed
13.
go back to reference Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Lainas GT, Cazlaris HE, Kolibianakis EM (2007) Initiation of gnrh antagonist on day 1 of stimulation as compared to the long agonist protocol in pcos patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 22(6):1540–1546CrossRefPubMed Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Lainas GT, Cazlaris HE, Kolibianakis EM (2007) Initiation of gnrh antagonist on day 1 of stimulation as compared to the long agonist protocol in pcos patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 22(6):1540–1546CrossRefPubMed
14.
go back to reference Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22(1):141–146CrossRefPubMed Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22(1):141–146CrossRefPubMed
15.
go back to reference Esmailzadeh S, Faramarzi M, Jorsarai G (2005) Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology. Eur J Obstet Gynecol Reprod Biol 121(1):67–70CrossRefPubMed Esmailzadeh S, Faramarzi M, Jorsarai G (2005) Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology. Eur J Obstet Gynecol Reprod Biol 121(1):67–70CrossRefPubMed
16.
go back to reference Jung JH, Kim SH, Suh CS, Choi YM, Shin CJ, Kim JG, Moon SY, Lee JY (1997) Outcome of in vitro fertilization and embryo transfer in patients with multifollicular ovarian pattern in transvaginal ultrasonography. Korean J Obstet Gynecol 40(5):1002–1012 Jung JH, Kim SH, Suh CS, Choi YM, Shin CJ, Kim JG, Moon SY, Lee JY (1997) Outcome of in vitro fertilization and embryo transfer in patients with multifollicular ovarian pattern in transvaginal ultrasonography. Korean J Obstet Gynecol 40(5):1002–1012
17.
go back to reference Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84(4):932–937CrossRefPubMed Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84(4):932–937CrossRefPubMed
18.
go back to reference Sahu B, Ozturk O, Ranierri M, Serhal P (2008) Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 277(3):239–244CrossRefPubMed Sahu B, Ozturk O, Ranierri M, Serhal P (2008) Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 277(3):239–244CrossRefPubMed
19.
go back to reference Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM (2006) Gnrh-antagonists in ovarian stimulation for ivf in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13(5):628–638CrossRefPubMed Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM (2006) Gnrh-antagonists in ovarian stimulation for ivf in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13(5):628–638CrossRefPubMed
20.
go back to reference Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH, Tzeng CR (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19(9):1993–2000CrossRefPubMed Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH, Tzeng CR (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19(9):1993–2000CrossRefPubMed
21.
go back to reference Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman MA (2005) Use of a gnrh antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 50(2):84–90PubMed Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman MA (2005) Use of a gnrh antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 50(2):84–90PubMed
22.
go back to reference Choi JW, Kim CH, Lee HA, Hong SH, Nah HY, Lee YJ, Kim SH, Chae HD, Son YS, Kang BM (2005) Efficacy of controlled ovarian hyperstimulation using gnrh antagonist in women with polycystic ovary syndrome undergoing ivf-et. Korean J Obstet Gynecol 48(3):716–725 Choi JW, Kim CH, Lee HA, Hong SH, Nah HY, Lee YJ, Kim SH, Chae HD, Son YS, Kang BM (2005) Efficacy of controlled ovarian hyperstimulation using gnrh antagonist in women with polycystic ovary syndrome undergoing ivf-et. Korean J Obstet Gynecol 48(3):716–725
23.
go back to reference Kurzawa R, Ciepiela P, Baczkowski T, Safranow K, Brelik P (2008) Comparison of embryological and clinical outcome in gnrh antagonist vs. Gnrh agonist protocols for in vitro fertilization in pcos non-obese patients. A prospective randomized study. J Assist Reprod Genet 25(8):365–374CrossRefPubMed Kurzawa R, Ciepiela P, Baczkowski T, Safranow K, Brelik P (2008) Comparison of embryological and clinical outcome in gnrh antagonist vs. Gnrh agonist protocols for in vitro fertilization in pcos non-obese patients. A prospective randomized study. J Assist Reprod Genet 25(8):365–374CrossRefPubMed
24.
go back to reference Orvieto R, Nahum R, Meltcer S, Homburg R, Rabinson J, Anteby EY, Ashkenazi J (2009) Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Reprod Biomed Online 18(3):333–336CrossRefPubMed Orvieto R, Nahum R, Meltcer S, Homburg R, Rabinson J, Anteby EY, Ashkenazi J (2009) Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Reprod Biomed Online 18(3):333–336CrossRefPubMed
25.
go back to reference Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL (2006) The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 43(Pt 3):217–219CrossRefPubMed Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL (2006) The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 43(Pt 3):217–219CrossRefPubMed
26.
go back to reference Wei HJ, Young R, Kuo IL, Liaw CM, Chiang HS, Yeh CY (2009) Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients. Fertil Steril 91(5):1864–1868CrossRefPubMed Wei HJ, Young R, Kuo IL, Liaw CM, Chiang HS, Yeh CY (2009) Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients. Fertil Steril 91(5):1864–1868CrossRefPubMed
27.
go back to reference Yilmaz N, Pektas M, Tonguc E, Kilic S, Gulerman C, Gungor T, Mollamahmutoglu L (2008) The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res 34(3):384–391CrossRefPubMed Yilmaz N, Pektas M, Tonguc E, Kilic S, Gulerman C, Gungor T, Mollamahmutoglu L (2008) The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res 34(3):384–391CrossRefPubMed
28.
go back to reference Sayin NC, Gucer F, Balkanli-Kaplan P, Yuce MA, Ciftci S, Kucuk M, Yardim T (2003) Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 48(3):165–170PubMed Sayin NC, Gucer F, Balkanli-Kaplan P, Yuce MA, Ciftci S, Kucuk M, Yardim T (2003) Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 48(3):165–170PubMed
29.
go back to reference Adams JM, Taylor AE, Crowley WF Jr, Hall JE (2004) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89(9):4343–4350CrossRefPubMed Adams JM, Taylor AE, Crowley WF Jr, Hall JE (2004) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89(9):4343–4350CrossRefPubMed
30.
go back to reference Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY (2008) Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 23(8):1924–1931CrossRefPubMed Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY (2008) Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 23(8):1924–1931CrossRefPubMed
Metadata
Title
A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles
Authors
Yong Jin Kim
Seung-Yup Ku
Byung Chul Jee
Chang Suk Suh
Seok Hyun Kim
Young Min Choi
Jung Gu Kim
Shin Yong Moon
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 2/2010
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1401-9

Other articles of this Issue 2/2010

Archives of Gynecology and Obstetrics 2/2010 Go to the issue